Skip to main content
Clinical Trials/NCT04801524
NCT04801524CompletedNot Applicable

Text-based Reminders to Promote COVID-19 Vaccinations

University of California, Los Angeles1 site in 1 country250,000 target enrollmentStarted: February 7, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
250,000
Locations
1
Primary Endpoint
First COVID-19 Vaccine Appointment Scheduled at UCLA Health

Study Overview

Brief Summary

This study investigates whether and which type of text-based reminders affect the take-up of the COVID-19 vaccine.

Detailed Description

Our primary research question is whether vaccine takeup can be boosted by a text-message reminder encouraging eligible patients to schedule a vaccination appointment. Patients, when becoming eligible for receiving the COVID-19 vaccine at UCLA Health, will be first notified about their eligibility and encouraged to schedule a vaccination appointment via one of the channels (email, voice call, or snail mail) depending on the contact information available to UCLA Health. Eligible patients will also receive a text-message reminder after the initial invitation. Eight days after the first text reminder, patients eligible for our study will be randomized at a 1:6 ratio into a holdout control arm that does not receive a second text message vs. a text-message arm that receives a second text message.

Our secondary research question concerns which type of text reminder is more effective. To study this question, we will nest a 2x3 factorial design within the text-message arm. The first factor has two levels and is whether the text message focuses on patients' personal benefits or prosocial benefits. The second factor has three levels and is whether the text message highlights the early access patients have to the vaccine, whether it highlights that the vaccine offers the promise of a fresh start, or neither.

  • In the Holdout arm: patients will not receive a second text message about COVID-vaccine.

  • In the text-message arm, all participants will receive a text message that invites them to schedule their vaccination appointment and includes a link to the appointment website

  • In the Self-benefit sub-arm, participants will be reminded that the vaccine helps protect themselves from COVID.

  • In the Prosocial-benefit sub-arm, participants will be reminded that the vaccine helps protect their family, friends, and community from COVID.

  • In the Early access + self-benefit sub-arm, participants will be reminded that they have early access to COVID-19 vaccine and should take the opportunity to protect themselves from COVID.

  • In the Early access + prosocial-benefit sub-arm, participants will be reminded that they have early access to COVID-19 vaccine and should take the opportunity to protect their family, friends, community from COVID.

  • In the Fresh start + self-benefit sub-arm, participants will be reminded that the vaccine offers the promise of a fresh start and they should take the opportunity to protect themselves from COVID and chart a new path forward.

  • In the Early access + prosocial-benefit sub-arm, participants will be reminded that the vaccine offers the promise of a fresh start and they should take the opportunity to protect their family, friends, community from COVID and help our nation chart a new path forward.

Patients will enter our study on a rolling basis, as they become eligible to get the vaccine (and if they fit our inclusion criteria for receiving the second text message). Those in the text-message arm will receive the second text message on the workday on or closest to the 8th day following the first text message. Specifically, if t denotes the date of the first text message, then t+8 is the 8th day following the first text message.If t+8 is Saturday, the second text message will be sent on Friday; if t+8 is Sunday, the second text message will be sent on Monday. We will measure a) whether patients schedule a COVID-19 vaccination appointment for the first dose and b) whether and when patients get the first dose of COVID-19 vaccine.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
Double (Participant, Care Provider)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •All patients who satisfy the following criteria will be eligible to be included in our study:
  • •They have a mobile phone number or SMS capable phone number in UCLA Health's database
  • •They are eligible for receiving the COVID-19 vaccine at UCLA Health
  • •They have not already scheduled an appointment the day before the scheduled time of the text message
  • •They are at or above 18 years old

Exclusion Criteria

  • •Patients who already scheduled an appointment or obtained a COVID vaccine (at our collaborating health system or as documented in the California Immunization Registry (CAIR) https://cairweb.org) by the time our text message is sent will be excluded from the analysis.

Arms & Interventions

Holdout Arm

No Intervention

In the Holdout arm: patients will not receive a second text message about COVID-vaccine.

Self-benefit sub-arm

Experimental

In the Self-benefit sub-arm, participants will be reminded that the vaccine helps protect themselves from COVID.

Intervention: Self-benefit (Behavioral)

Prosocial-benefit sub-arm

Experimental

In the Prosocial-benefit sub-arm, participants will be reminded that the vaccine helps protect their family, friends, and community from COVID.

Intervention: Prosocial-benefit (Behavioral)

Early-access and self-benefit sub-arm

Experimental

In the Early access + self-benefit sub-arm, participants will be reminded that they have early access to COVID-19 vaccine and should take the opportunity to protect themselves from COVID.

Intervention: Self-benefit (Behavioral)

Early-access and self-benefit sub-arm

Experimental

In the Early access + self-benefit sub-arm, participants will be reminded that they have early access to COVID-19 vaccine and should take the opportunity to protect themselves from COVID.

Intervention: Early access (Behavioral)

Early-access and prosocial-benefit sub-arm

Experimental

In the Early access + prosocial-benefit sub-arm, participants will be reminded that they have early access to COVID-19 vaccine and should take the opportunity to protect their family, friends, community from COVID.

Intervention: Prosocial-benefit (Behavioral)

Early-access and prosocial-benefit sub-arm

Experimental

In the Early access + prosocial-benefit sub-arm, participants will be reminded that they have early access to COVID-19 vaccine and should take the opportunity to protect their family, friends, community from COVID.

Intervention: Early access (Behavioral)

Fresh start and self-benefit sub-arm

Experimental

In the Fresh start + self-benefit sub-arm, participants will be reminded that the vaccine offers the promise of a fresh start and they should take the opportunity to protect themselves from COVID and chart a new path forward.

Intervention: Self-benefit (Behavioral)

Fresh start and self-benefit sub-arm

Experimental

In the Fresh start + self-benefit sub-arm, participants will be reminded that the vaccine offers the promise of a fresh start and they should take the opportunity to protect themselves from COVID and chart a new path forward.

Intervention: Fresh start (Behavioral)

Fresh start and prosocial-benefit sub-arm

Experimental

In the Early access + prosocial-benefit sub-arm, participants will be reminded that the vaccine offers the promise of a fresh start and they should take the opportunity to protect their family, friends, community from COVID and help our nation chart a new path forward.

Intervention: Prosocial-benefit (Behavioral)

Fresh start and prosocial-benefit sub-arm

Experimental

In the Early access + prosocial-benefit sub-arm, participants will be reminded that the vaccine offers the promise of a fresh start and they should take the opportunity to protect their family, friends, community from COVID and help our nation chart a new path forward.

Intervention: Fresh start (Behavioral)

Outcomes

Primary Outcomes

First COVID-19 Vaccine Appointment Scheduled at UCLA Health

Time Frame: 6 days

Whether patients schedule their vaccination appointment at UCLA Health within 6 days of receiving the second text message (including the day of text message). Specifically, if t=the date of the second text message (for the holdout arm, this refers to the date they would have received the text message had they not been assigned to the holdout arm), we will track vaccination appointments made by the end of t+5. While most people just make one appointment, a small percentage update their appointment time. We will have access to the latest few first-dose appointments people schedule by the time of data extraction.

Secondary Outcomes

  • Time of obtaining the first COVID-19 vaccine at UCLA Health(1 months from text message)
  • First COVID-19 Vaccine obtained at UCLA Health or any organization reporting to CAIR(2 months from text message)
  • Time of obtaining the first COVID-19 at UCLA Health or another location reporting to CAIR(2 months from text message)
  • First COVID-19 Vaccine obtained at UCLA Health(1 months from text message)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Daniel M. Croymans, MD, MBA, MS

Medical Director of Quality, Dept of Medicine

University of California, Los Angeles

Study Sites (1)

Loading locations...

Similar Trials

Text-based Reminders to Promote COVID-19... | Clinical Trial